Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $1.7 million.

  • Arcadia Biosciences' Non Operating Income rose 1122000.0% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 136222.22%. This contributed to the annual value of $31000.0 for FY2024, which is 3541.67% down from last year.
  • As of Q3 2025, Arcadia Biosciences' Non Operating Income stood at $1.7 million, which was up 1122000.0% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Non Operating Income registered a high of $7.5 million during Q1 2021, and its lowest value of -$137000.0 during Q4 2024.
  • Its 5-year average for Non Operating Income is $720666.7, with a median of $14500.0 in 2022.
  • As far as peak fluctuations go, Arcadia Biosciences' Non Operating Income skyrocketed by 2749000.0% in 2021, and later crashed by 124166.67% in 2024.
  • Over the past 5 years, Arcadia Biosciences' Non Operating Income (Quarter) stood at -$100000.0 in 2021, then surged by 96.0% to -$4000.0 in 2022, then surged by 400.0% to $12000.0 in 2023, then tumbled by 1241.67% to -$137000.0 in 2024, then surged by 1339.42% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.1 million for Q2 2025, and -$137000.0 during Q4 2024.